Llorens Pharmaceutical Urin D/S Tablets Methenamine 81.6 mg, Sodium Biphosphate 40.8 mg recall — FDA D-0081-2018
Superpotent Drug: Subpotent Drug. FDA analysis found this product to be Out of Specification for assay which could result in either Subpotent and/or Superpotent tablets.